The Human Factors and Ergonomics Society Presents Symposium on Health Care Featuring Technologies and Techniques to Transform Training, Safety and Success in Healthcare

The Human Factors and Ergonomics Society (HFES) will host the 12th International Symposium on Human Factors and Ergonomics in Healthcare on March 26-29, 2023, at the Loews Sapphire Falls Resort in Orlando, FL. This event serves as the premiere conference at the intersection of human factors and health care and will feature fivetracks, including Digital Health, Hospital Environments, Patient Safety Research and Initiatives, Education and Simulation and Medical and Drug Delivery Devices.

“This event will highlight how technology is rapidly and directly evolving the health care system and how leveraging human factors can help avoid critical medical errors and improve patient and provider well-being,” said Joseph R. Keebler, Ph.D., HFES’s Health Care Symposium Chair. “Attendees will gain an unprecedented understanding of current cutting-edge research and technology in the health care environment where human factors and ergonomics principles should be applied to improve medical device design, optimize team performance in hospitals, and improve patient safety. It will also uncover new insights into emerging issues such as artificial intelligence in medical decision making and burnout among nurses, doctors and staff.”

The keynote address will be given by Peter Weinstock, MD, Ph.D., Executive Program Director of Immersive Design Systems and Anesthesiology Endowed Chair in Pediatric Simulation at Boston Children’s Hospital. The title of his address is “Immersive Technologies to Transform Training, Safety, and Experience in Health Care” and will be held on Monday, March 27, from 8:30 a.m. – 10:00 a.m. in Grand Caribbean 6.

Other sessions will include several topics, including virtual reality in health care, digital health, artificial intelligence (AI), connected medical devices, simulations to improve design, training and coordination, and much more. The symposium will also announce the winners of the student design competition for Mobile Health Applications for End Users. Entries showcase the application of human factors/ergonomics (HF/E) methods and design principles for the design of a mobile health application for end users and how an HF/E approach to such an application can lead to a useful, usable, and satisfying user experience while simultaneously improving patient outcomes such as knowledge, safety, adherence, or health.

For those who may be unable to join the event in Orlando in person, more than 30 Sessions in the Medical and Drug-Delivery Device and Digital Health tracks as well as the keynote address will be live-streamed from the event and available as session recordings at a later date. Visit this link to register for virtual access: https://www.hcs-2023.org/virtual-access.

For more details and additional information on the event, please visit https://www.hcs-2023.org.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”